Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR
Overview
Authors
Affiliations
Rationale & Objective: Use of cystatin C in addition to creatinine to estimate glomerular filtration rate (estimated glomerular filtration rate based on cystatin C [eGFRcys] and estimated glomerular filtration rate based on creatinine [eGFRcr], respectively) is increasing. When eGFRcr and eGFRcys are discordant, it is not known which is more accurate, leading to uncertainty in clinical decision making.
Study Design: Cross-sectional analysis.
Setting & Participants: Four thousand fifty participants with measured glomerular filtration rate (mGFR) from 12 studies in North America and Europe.
Exposures: Serum creatinine and serum cystatin C.
Outcomes: Performance of creatinine-based and cystatin C-based glomerular filtration rate estimating equations compared to mGFR.
Analytical Approach: We evaluated the accuracy of eGFRcr, eGFRcys, and the combination (eGFRcr-cys) compared to mGFR according to the magnitude of the difference between eGFRcr and eGFRcys (eGFRdiff). We used CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations to estimate glomerular filtration rate. eGFRdiff was defined as eGFRcys minus eGFRcr and categorized as less than -15, -15 to <15, and ≥15 mL/min/1.73 m (negative, concordant, and positive groups, respectively). We compared bias (median of mGFR minus eGFR) and the percentage of eGFR within 30% of mGFR.
Results: Thirty percent of participants had discordant eGFRdiff (21.0% and 9.6% negative and positive eGFRdiffs, respectively). In the concordant eGFRdiff group, all equations displayed similar accuracy. In the negative eGFRdiff groups, eGFRcr had a large overestimation of mGFR (-13.4 [-14.5 to -12.2] mL/min/1.73 m) and eGFRcys had a large underestimation (9.9 [9.1-11.2] mL/min/1.73m), with opposite results in the positive eGFRdiff group. In both negative and positive eGFRdiff groups, eGFRcr-cys was more accurate than either eGFRcr or eGFRcys. These results were largely consistent across age, sex, race, and body mass index.
Limitations: Few participants with major comorbid conditions.
Conclusions: Discordant eGFRcr and eGFRcys are common. eGFR using the combination of creatinine and cystatin C provides the most accurate estimates among persons with discordant eGFRcr or eGFRcys.
Fino N, Inker L, Greene T, Adingwupu O, Coresh J, Seegmiller J PLoS One. 2024; 19(12):e0313154.
PMID: 39621675 PMC: 11611103. DOI: 10.1371/journal.pone.0313154.
Hernandez B, Wieruszewski P, Barreto J, Cole K, Damani S, Kane-Gill S Pharmacotherapy. 2024; 44(12):898-906.
PMID: 39601345 PMC: 11693467. DOI: 10.1002/phar.4627.
Wang Z, Wang S, Zhao M, He Q Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(9):1002-1008.
PMID: 39267519 PMC: 11404467. DOI: 10.7499/j.issn.1008-8830.2401011.
CYSTATIN C-A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes.
Visinescu A, Rusu E, Cosoreanu A, Radulian G Int J Mol Sci. 2024; 25(15).
PMID: 39125705 PMC: 11311327. DOI: 10.3390/ijms25158135.
Chen D, Lu K, Scherzer R, Lees J, Rutherford E, Mark P Kidney Med. 2024; 6(4):100796.
PMID: 38567244 PMC: 10986041. DOI: 10.1016/j.xkme.2024.100796.